123 related articles for article (PubMed ID: 3764228)
1. A simulation study of three sequential methods for the comparison of two treatment groups when the response criterion is censored.
Benichou J; Chastang C
Stat Med; 1986; 5(4):375-85. PubMed ID: 3764228
[TBL] [Abstract][Full Text] [Related]
2. [Application of sequential methods in randomized clinical trials with censored response criteria].
Benichou J; Chastang C
Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
[TBL] [Abstract][Full Text] [Related]
3. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
Bénichou J; Lepage E; Chastang C
Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four sequential methods allowing for early stopping of comparative clinical trials.
Sebille V; Bellissant E
Clin Sci (Lond); 2000 May; 98(5):569-78. PubMed ID: 10781388
[TBL] [Abstract][Full Text] [Related]
5. Sequential boundaries approach in clinical trials with unequal allocation ratios.
Jafari P; Ayatollahi SM; Behboodian J
BMC Med Res Methodol; 2006 Jan; 6():1. PubMed ID: 16412232
[TBL] [Abstract][Full Text] [Related]
6. Response adaptive designs with a variance-penalized criterion.
Yi Y; Wang X
Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
[TBL] [Abstract][Full Text] [Related]
7. Analysis of phase II clinical trials in haematology and oncology: comparison of the triangular test to the usual methods.
Benichou J; Bellissant E; Chastang C
Stat Med; 1991 Jun; 10(6):989; discussion 989-90. PubMed ID: 1876789
[TBL] [Abstract][Full Text] [Related]
8. Optimal adaptive designs for binary response trials.
Rosenberger WF; Stallard N; Ivanova A; Harper CN; Ricks ML
Biometrics; 2001 Sep; 57(3):909-13. PubMed ID: 11550944
[TBL] [Abstract][Full Text] [Related]
9. Investigating maximum power losses in survival studies with nonstratified randomization.
Palta M
Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
[TBL] [Abstract][Full Text] [Related]
10. [Design and analysis of phase II trials in oncology with a group sequential method, the triangular test].
Bellissant E; Bénichou J; Chastang C
Therapie; 1991; 46(1):21-7. PubMed ID: 2020920
[TBL] [Abstract][Full Text] [Related]
11. Group sequential clinical trials with triangular continuation regions.
Whitehead J; Stratton I
Biometrics; 1983 Mar; 39(1):227-36. PubMed ID: 6871351
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
Tan M; Xiong X; Kutner MH
Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
[TBL] [Abstract][Full Text] [Related]
13. Application of the triangular test to phase II cancer clinical trials.
Bellissant E; Benichou J; Chastang C
Stat Med; 1990 Aug; 9(8):907-17. PubMed ID: 2218193
[TBL] [Abstract][Full Text] [Related]
14. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
15. The effect of unbalanced randomization on the progressively censored Savage test.
Lesser ML
Stat Med; 1982; 1(3):277-80. PubMed ID: 7187100
[TBL] [Abstract][Full Text] [Related]
16. A useful design utilizing the information fraction in a group sequential clinical trial with censored survival data.
Hsu CY; Chen CH; Hsu KN; Lu YH
Biometrics; 2019 Mar; 75(1):133-143. PubMed ID: 30004574
[TBL] [Abstract][Full Text] [Related]
17. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
18. The use of the triangular test with response-adaptive treatment allocation.
Coad DS; Ivanova A
Stat Med; 2005 May; 24(10):1483-93. PubMed ID: 15706635
[TBL] [Abstract][Full Text] [Related]
19. Matching on-the-fly: sequential allocation with higher power and efficiency.
Kapelner A; Krieger A
Biometrics; 2014 Jun; 70(2):378-88. PubMed ID: 24484195
[TBL] [Abstract][Full Text] [Related]
20. A two-stage design for choosing among several experimental treatments and a control in clinical trials.
Thall PF; Simon R; Ellenberg SS
Biometrics; 1989 Jun; 45(2):537-47. PubMed ID: 2765637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
